- Home
- OMH vs SBFM Comparison
OMH vs SBFM Comparison
Compare OMH & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- SBFM
- Stock Information
- Founded
- OMH 2015
- SBFM 2006
- Country
- OMH Singapore
- SBFM United States
- Employees
- OMH N/A
- SBFM N/A
- Industry
- OMH Real Estate
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- SBFM Health Care
- Exchange
- OMH Nasdaq
- SBFM Nasdaq
- Market Cap
- OMH 35.8M
- SBFM 6.6M
- IPO Year
- OMH 2023
- SBFM N/A
- Fundamental
- Price
- OMH $1.27
- SBFM $1.47
- Analyst Decision
- OMH Hold
- SBFM Strong Buy
- Analyst Count
- OMH 1
- SBFM 1
- Target Price
- OMH N/A
- SBFM $15.00
- AVG Volume (30 Days)
- OMH 229.1K
- SBFM 43.5K
- Earning Date
- OMH 09-25-2025
- SBFM 11-04-2025
- Dividend Yield
- OMH N/A
- SBFM N/A
- EPS Growth
- OMH N/A
- SBFM N/A
- EPS
- OMH N/A
- SBFM N/A
- Revenue
- OMH $7,976,578.00
- SBFM $36,341,741.00
- Revenue This Year
- OMH $28.40
- SBFM $32.20
- Revenue Next Year
- OMH $23.07
- SBFM $32.74
- P/E Ratio
- OMH N/A
- SBFM N/A
- Revenue Growth
- OMH 117.53
- SBFM 19.22
- 52 Week Low
- OMH $0.59
- SBFM $1.17
- 52 Week High
- OMH $5.46
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- OMH 52.49
- SBFM 52.22
- Support Level
- OMH $1.08
- SBFM $1.45
- Resistance Level
- OMH $1.39
- SBFM $1.53
- Average True Range (ATR)
- OMH 0.13
- SBFM 0.06
- MACD
- OMH 0.02
- SBFM 0.01
- Stochastic Oscillator
- OMH 40.87
- SBFM 68.57
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.